Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 1;12(4):89.
doi: 10.3390/dj12040089.

Prospective Cohort Study Identifies Medical Predictors of Treatment-Related Oral Toxicities in Oral and Oropharyngeal Cancer Patients

Affiliations

Prospective Cohort Study Identifies Medical Predictors of Treatment-Related Oral Toxicities in Oral and Oropharyngeal Cancer Patients

Leticia Rodrigues-Oliveira et al. Dent J (Basel). .

Abstract

The dental treatment of patients with oral cavity and oropharyngeal squamous cell carcinoma (OOPSCC) may be challenging for dentists. This study aimed to characterize systemic changes in patients with OOPSCC undergoing dental treatment prior to cancer therapy, with a specific focus on laboratory assessments. The primary objectives included identifying potential adverse events, such as infections or bleeding, resulting from dental procedures. Additionally, the study aimed to correlate baseline patient characteristics with treatment-related toxicities. This was a prospective cohort study that included 110 OOPSCC patients referred to the Dental Oncology Service at São Paulo State Cancer Institute, Brazil, between November/2019 and December/2020. Comorbidities, sociodemographic data, medication in use, cancer treatment-related toxicities, and altered laboratory tests results were correlated. The most common comorbidities and altered laboratory results were hypertension, dyslipidemia, diabetes, as well as elevated levels of C-reactive protein, hemoglobin, and hematocrit. Toxicities exhibited a progressive pattern over time, encompassing oral mucositis (OM), xerostomia, dysphagia, dysgeusia, trismus, and radiodermatitis. No correlation between comorbidities and cancer treatment-related toxicities, a positive correlation between medications in use and OM, and a negative correlation between medications and dysgeusia were found. OM was associated with altered thyroxine (T4) and free thyroxine (FT4), calcium, urea, creatinine, alkaline phosphatase, and syphilis. Family income and housing were OM predictors. Altered T4/FT4/urea/calcium/alkaline phosphatase/creatinine/syphilis may be useful clinical predictors of OM. Despite the elevated prevalence of comorbidities and abnormal laboratory findings, dental treatment prior to cancer treatment yielded no adverse events.

Keywords: comorbidity; dental care; medical examination; medical history; oral cancer; oropharyngeal cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Heat map of oral mucositis predictors. The image above depicts the oral mucositis predictors based on our total, full, continuous, and discrete datasets. The predictors were tested across all the data in this investigation. The most important factors are family income and housing.

Similar articles

References

    1. Epstein J.B., Güneri P., Barasch A. Appropriate and necessary oral care for people with cancer: Guidance to obtain the right oral and dental care at the right time. Support. Care Cancer. 2014;22:1981–1988. doi: 10.1007/s00520-014-2228-x. - DOI - PubMed
    1. Levi L.E., Lalla R.V. Dental Treatment Planning for the Patient with Oral Cancer. Dent. Clin. N. Am. 2018;62:121–130. doi: 10.1016/j.cden.2017.08.009. - DOI - PubMed
    1. Carvalho C.G., Medeiros-Filho J.B., Ferreira M.C. Guide for health professionals addressing oral care for individuals in oncological treatment based on scientific evidence. Support. Care Cancer. 2018;26:2651–2661. doi: 10.1007/s00520-018-4111-7. - DOI - PubMed
    1. Rodrigues-Oliveira L., Kowalski L.P., Santos M., Marta G.N., Bensadoun R.-J., Martins M.D., Lopes M.A., de Castro G., William W.N., Chaves A.L.F., et al. Direct costs associated with the management of mucositis: A systematic review. Oral Oncol. 2021;118:105296. doi: 10.1016/j.oraloncology.2021.105296. - DOI - PubMed
    1. McGuire D.B. Barriers and strategies in implementation of oral care standards for cancer patients. Support. Care Cancer. 2003;11:435–441. doi: 10.1007/s00520-003-0466-4. - DOI - PubMed